azam & associates healthcare ltd Company Information
Company Number
07205389
Next Accounts
Dec 2025
Directors
Shareholders
wajid mohmood azam
nadia wajid
Group Structure
View All
Industry
Dental practice activities
Registered Address
32 prescott street, halifax, west yorkshire, HX1 2QW
Website
www.wazam.co.ukazam & associates healthcare ltd Estimated Valuation
Pomanda estimates the enterprise value of AZAM & ASSOCIATES HEALTHCARE LTD at £906k based on a Turnover of £1.6m and 0.57x industry multiple (adjusted for size and gross margin).
azam & associates healthcare ltd Estimated Valuation
Pomanda estimates the enterprise value of AZAM & ASSOCIATES HEALTHCARE LTD at £851.7k based on an EBITDA of £236.2k and a 3.61x industry multiple (adjusted for size and gross margin).
azam & associates healthcare ltd Estimated Valuation
Pomanda estimates the enterprise value of AZAM & ASSOCIATES HEALTHCARE LTD at £3.9m based on Net Assets of £1.5m and 2.6x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Azam & Associates Healthcare Ltd Overview
Azam & Associates Healthcare Ltd is a live company located in west yorkshire, HX1 2QW with a Companies House number of 07205389. It operates in the dental practice activities sector, SIC Code 86230. Founded in March 2010, it's largest shareholder is wajid mohmood azam with a 90% stake. Azam & Associates Healthcare Ltd is a established, small sized company, Pomanda has estimated its turnover at £1.6m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Azam & Associates Healthcare Ltd Health Check
Pomanda's financial health check has awarded Azam & Associates Healthcare Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 1 areas for improvement. Company Health Check FAQs


7 Strong

4 Regular

1 Weak

Size
annual sales of £1.6m, make it larger than the average company (£970k)
- Azam & Associates Healthcare Ltd
£970k - Industry AVG

Growth
3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (6.4%)
- Azam & Associates Healthcare Ltd
6.4% - Industry AVG

Production
with a gross margin of 50%, this company has a comparable cost of product (50%)
- Azam & Associates Healthcare Ltd
50% - Industry AVG

Profitability
an operating margin of 12% make it more profitable than the average company (8.9%)
- Azam & Associates Healthcare Ltd
8.9% - Industry AVG

Employees
with 12 employees, this is similar to the industry average (11)
12 - Azam & Associates Healthcare Ltd
11 - Industry AVG

Pay Structure
on an average salary of £22.2k, the company has an equivalent pay structure (£22.2k)
- Azam & Associates Healthcare Ltd
£22.2k - Industry AVG

Efficiency
resulting in sales per employee of £132.2k, this is more efficient (£92.9k)
- Azam & Associates Healthcare Ltd
£92.9k - Industry AVG

Debtor Days
it gets paid by customers after 18 days, this is later than average (7 days)
- Azam & Associates Healthcare Ltd
7 days - Industry AVG

Creditor Days
its suppliers are paid after 24 days, this is close to average (25 days)
- Azam & Associates Healthcare Ltd
25 days - Industry AVG

Stock Days
it holds stock equivalent to 2 days, this is less than average (11 days)
- Azam & Associates Healthcare Ltd
11 days - Industry AVG

Cash Balance
has cash to cover current liabilities for 226 weeks, this is more cash available to meet short term requirements (1 weeks)
226 weeks - Azam & Associates Healthcare Ltd
1 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 17.1%, this is a lower level of debt than the average (49.3%)
17.1% - Azam & Associates Healthcare Ltd
49.3% - Industry AVG
AZAM & ASSOCIATES HEALTHCARE LTD financials

Azam & Associates Healthcare Ltd's latest turnover from March 2024 is estimated at £1.6 million and the company has net assets of £1.5 million. According to their latest financial statements, Azam & Associates Healthcare Ltd has 12 employees and maintains cash reserves of £620.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 12 | 13 | 14 | 11 | 13 | 12 | 12 | 10 | 10 | |||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 210,251 | 115,515 | 47,480 | 48,613 | 53,363 | 59,756 | 52,404 | 50,956 | 53,499 | 57,182 | 63,675 | 70,381 | 68,053 | 62,199 |
Intangible Assets | 70,000 | 140,000 | 210,000 | 280,000 | 350,000 | 420,000 | 490,000 | 560,000 | 630,000 | 700,000 | ||||
Investments & Other | ||||||||||||||
Debtors (Due After 1 year) | ||||||||||||||
Total Fixed Assets | 210,251 | 115,515 | 47,480 | 48,613 | 123,363 | 199,756 | 262,404 | 330,956 | 403,499 | 477,182 | 553,675 | 630,381 | 698,053 | 762,199 |
Stock & work in progress | 4,896 | 4,814 | 4,853 | 5,173 | 4,703 | 4,582 | 4,082 | 4,100 | 4,000 | 4,077 | 4,065 | 4,012 | 3,996 | |
Trade Debtors | 78,519 | 68,378 | 74,043 | 69,832 | 58,414 | 42,489 | 56,755 | 51,382 | 49,847 | 51,390 | 49,339 | 48,065 | 46,616 | 55,409 |
Group Debtors | ||||||||||||||
Misc Debtors | 872,520 | 638,519 | 448,719 | 520,910 | 342,561 | 312,745 | 163,622 | 111,352 | 56,061 | |||||
Cash | 620,608 | 714,316 | 635,138 | 359,879 | 240,967 | 104,253 | 87,579 | 44 | 33 | 76 | 82 | 1,096 | 72 | |
misc current assets | ||||||||||||||
total current assets | 1,576,543 | 1,426,027 | 1,162,753 | 955,794 | 646,645 | 464,069 | 312,038 | 166,878 | 109,941 | 55,543 | 53,486 | 53,173 | 50,684 | 55,409 |
total assets | 1,786,794 | 1,541,542 | 1,210,233 | 1,004,407 | 770,008 | 663,825 | 574,442 | 497,834 | 513,440 | 532,725 | 607,161 | 683,554 | 748,737 | 817,608 |
Bank overdraft | 5,764 | 1,658 | 16,705 | |||||||||||
Bank loan | ||||||||||||||
Trade Creditors | 53,942 | 68,786 | 105,426 | 76,088 | 39,990 | 44,309 | 37,475 | 34,213 | 28,775 | 161,072 | 244,971 | 365,188 | 509,808 | 124,320 |
Group/Directors Accounts | ||||||||||||||
other short term finances | ||||||||||||||
hp & lease commitments | 22,934 | 9,123 | ||||||||||||
other current liabilities | 65,847 | 74,753 | 71,137 | 95,103 | 69,975 | 64,090 | 66,747 | 58,704 | 66,427 | |||||
total current liabilities | 142,723 | 152,662 | 176,563 | 171,191 | 109,965 | 108,399 | 109,986 | 94,575 | 111,907 | 161,072 | 244,971 | 365,188 | 509,808 | 124,320 |
loans | ||||||||||||||
hp & lease commitments | 124,062 | 56,928 | ||||||||||||
Accruals and Deferred Income | ||||||||||||||
other liabilities | 482,270 | |||||||||||||
provisions | 38,920 | 20,419 | 7,157 | 7,373 | 7,866 | 8,017 | 6,656 | 5,954 | 10,699 | 5,134 | 5,050 | 3,602 | 668 | |
total long term liabilities | 162,982 | 77,347 | 7,157 | 7,373 | 7,866 | 8,017 | 6,656 | 5,954 | 10,699 | 5,134 | 5,050 | 3,602 | 668 | 482,270 |
total liabilities | 305,705 | 230,009 | 183,720 | 178,564 | 117,831 | 116,416 | 116,642 | 100,529 | 122,606 | 166,206 | 250,021 | 368,790 | 510,476 | 606,590 |
net assets | 1,481,089 | 1,311,533 | 1,026,513 | 825,843 | 652,177 | 547,409 | 457,800 | 397,305 | 390,834 | 366,519 | 357,140 | 314,764 | 238,261 | 211,018 |
total shareholders funds | 1,481,089 | 1,311,533 | 1,026,513 | 825,843 | 652,177 | 547,409 | 457,800 | 397,305 | 390,834 | 366,519 | 357,140 | 314,764 | 238,261 | 211,018 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 45,169 | 21,378 | 4,421 | 4,750 | 6,393 | 7,941 | 5,907 | 5,374 | 6,176 | 7,067 | 8,691 | 10,368 | 11,711 | 14,637 |
Amortisation | 70,000 | 70,000 | 70,000 | 70,000 | 70,000 | 70,000 | 70,000 | 70,000 | 70,000 | 70,000 | ||||
Tax | ||||||||||||||
Stock | 82 | -39 | -320 | 470 | 121 | 500 | -18 | 100 | -77 | 12 | 53 | 16 | 3,996 | |
Debtors | 244,142 | 184,135 | -67,980 | 189,767 | 45,741 | 134,857 | 57,643 | 56,826 | 54,518 | 2,051 | 1,274 | 1,449 | -8,793 | 55,409 |
Creditors | -14,844 | -36,640 | 29,338 | 36,098 | -4,319 | 6,834 | 3,262 | 5,438 | -132,297 | -83,899 | -120,217 | -144,620 | 385,488 | 124,320 |
Accruals and Deferred Income | -8,906 | 3,616 | -23,966 | 25,128 | 5,885 | -2,657 | 8,043 | -7,723 | 66,427 | |||||
Deferred Taxes & Provisions | 18,501 | 13,262 | -216 | -493 | -151 | 1,361 | 702 | -4,745 | 5,565 | 84 | 1,448 | 2,934 | 668 | |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | ||||||||||||||
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | ||||||||||||||
Group/Directors Accounts | ||||||||||||||
Other Short Term Loans | ||||||||||||||
Long term loans | ||||||||||||||
Hire Purchase and Lease Commitments | 80,945 | 66,051 | ||||||||||||
other long term liabilities | -482,270 | 482,270 | ||||||||||||
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -93,708 | 79,178 | 275,259 | 118,912 | 136,714 | 16,674 | 87,535 | 11 | -43 | -6 | -1,014 | 1,024 | 72 | |
overdraft | -5,764 | 4,106 | -15,047 | 16,705 | ||||||||||
change in cash | -93,708 | 79,178 | 275,259 | 118,912 | 136,714 | 22,438 | 83,429 | 15,058 | -16,748 | -6 | -1,014 | 1,024 | 72 |
azam & associates healthcare ltd Credit Report and Business Information
Azam & Associates Healthcare Ltd Competitor Analysis

Perform a competitor analysis for azam & associates healthcare ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in HX1 area or any other competitors across 12 key performance metrics.
azam & associates healthcare ltd Ownership
AZAM & ASSOCIATES HEALTHCARE LTD group structure
Azam & Associates Healthcare Ltd has no subsidiary companies.
Ultimate parent company
AZAM & ASSOCIATES HEALTHCARE LTD
07205389
azam & associates healthcare ltd directors
Azam & Associates Healthcare Ltd currently has 1 director, Dr Wajid Azam serving since Mar 2010.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Wajid Azam | England | 54 years | Mar 2010 | - | Director |
P&L
March 2024turnover
1.6m
+8%
operating profit
191k
0%
gross margin
50%
+1.87%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
1.5m
+0.13%
total assets
1.8m
+0.16%
cash
620.6k
-0.13%
net assets
Total assets minus all liabilities
azam & associates healthcare ltd company details
company number
07205389
Type
Private limited with Share Capital
industry
86230 - Dental practice activities
incorporation date
March 2010
age
15
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
32 prescott street, halifax, west yorkshire, HX1 2QW
Bank
-
Legal Advisor
-
azam & associates healthcare ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to azam & associates healthcare ltd.
azam & associates healthcare ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AZAM & ASSOCIATES HEALTHCARE LTD. This can take several minutes, an email will notify you when this has completed.
azam & associates healthcare ltd Companies House Filings - See Documents
date | description | view/download |
---|